Maraviroc

Hepatotoxicity

  • Hepatotoxicity has been reported with use of maraviroc
  • Severe rash or evidence of a systemic allergic reactions (e.g., fever, eosinophilia, or elevated IgE) prior to the development of hepatotoxicity may occur.
  • Patients with signs or symptoms of hepatitis or allergic reaction following use of maravoic should be evaluated immediately [See Warnings and Precautions in package insert]

Patient counseling

Medical guidelines

Package inserts

Additional information

Updated: January 2018